Cutera, Inc. Share Price

Equities

CUTR

US2321091082

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 01:30:00 19/06/2024 am IST 5-day change 1st Jan Change
1.63 USD -1.81% Intraday chart for Cutera, Inc. -13.30% -53.76%
Sales 2024 * 16Cr 1.35TCr Sales 2025 * 18Cr 1.46TCr Capitalization 3.28Cr 273.58Cr
Net income 2024 * -13Cr -1.05TCr Net income 2025 * -7.7Cr -643.04Cr EV / Sales 2024 * 0.2 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 0.19 x
P/E ratio 2024 *
-0.33 x
P/E ratio 2025 *
-0.39 x
Employees 430
Yield 2024 *
-
Yield 2025 *
-
Free-Float 97.9%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.81%
1 week-13.30%
Current month-24.19%
1 month-26.58%
3 months-17.68%
6 months-38.61%
Current year-53.76%
More quotes
1 week
1.60
Extreme 1.6
1.86
1 month
1.60
Extreme 1.6
2.37
Current year
1.28
Extreme 1.2801
4.97
1 year
1.28
Extreme 1.2801
21.41
3 years
1.28
Extreme 1.2801
74.38
5 years
1.28
Extreme 1.2801
74.38
10 years
1.28
Extreme 1.2801
74.38
More quotes
Managers TitleAgeSince
Chief Executive Officer 48 19/23/19
Director of Finance/CFO 58 01/21/01
Chief Tech/Sci/R&D Officer 61 01/19/01
Members of the board TitleAgeSince
Director/Board Member 65 01/23/01
Chief Executive Officer 48 19/23/19
Chairman 64 19/23/19
More insiders
Date Price Change Volume
18/24/18 1.63 -1.81% 247,185
17/24/17 1.66 -8.79% 600,030
14/24/14 1.82 +1.68% 219,618
13/24/13 1.79 -4.79% 433,549
12/24/12 1.88 +0.53% 376,440

Delayed Quote Nasdaq, June 19, 2024 at 01:30 am IST

More quotes
Cutera, Inc. develops, manufactures, distributes, and markets energy-based product platforms for medical practitioners, enabling them to offer treatments to their customers. The Company distributes third-party manufactured skincare products and secret systems and consumables. Its system platforms include AviClear, enlighten, excel, truSculpt, Secret PRO, Secret RF, and xeo. The Company’s Cutera Core segment consists of the Company’s systems, consumables, skincare, and service businesses. The Cutera Core segment develops, distributes and manufactures energy-based systems for medical practitioners in addition to distributing third-party manufactured skincare products in Japan. The Company’s AviClear segment consists of the AviClear business. The Company’s acne solution, AviClear, is a prescription-free, drug-free laser treatment for the treatment of mild to severe acne. Its products include CUTERA, ACUTIP 500, AVITM, AVI360, AVIANALYTICSTM, AVICARE COOLGLIDE, and more.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
1.63 USD
Average target price
6.333 USD
Spread / Average Target
+288.55%
Consensus